164 related articles for article (PubMed ID: 15628866)
1. Mechanism of time-dependent inhibition of polypeptide deformylase by actinonin.
Van Aller GS; Nandigama R; Petit CM; DeWolf WE; Quinn CJ; Aubart KM; Zalacain M; Christensen SB; Copeland RA; Lai Z
Biochemistry; 2005 Jan; 44(1):253-60. PubMed ID: 15628866
[TBL] [Abstract][Full Text] [Related]
2. Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial peptide deformylase.
Grant SK; Green BG; Kozarich JW
Bioorg Chem; 2001 Aug; 29(4):211-22. PubMed ID: 16256693
[TBL] [Abstract][Full Text] [Related]
3. Understanding the origins of time-dependent inhibition by polypeptide deformylase inhibitors.
Totoritis R; Duraiswami C; Taylor AN; Kerrigan JJ; Campobasso N; Smith KJ; Ward P; King BW; Murrayz-Thompson M; Jones AD; Van Aller GS; Aubart KM; Zalacain M; Thrall SH; Meek TD; Schwartz B
Biochemistry; 2011 Aug; 50(31):6642-54. PubMed ID: 21711014
[TBL] [Abstract][Full Text] [Related]
4. Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor.
Chen DZ; Patel DV; Hackbarth CJ; Wang W; Dreyer G; Young DC; Margolis PS; Wu C; Ni ZJ; Trias J; White RJ; Yuan Z
Biochemistry; 2000 Feb; 39(6):1256-62. PubMed ID: 10684604
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of peptide deformylase from Staphylococcus aureus in complex with actinonin, a naturally occurring antibacterial agent.
Yoon HJ; Kim HL; Lee SK; Kim HW; Kim HW; Lee JY; Mikami B; Suh SW
Proteins; 2004 Nov; 57(3):639-42. PubMed ID: 15382235
[No Abstract] [Full Text] [Related]
6. Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents.
Calí P; Naerum L; Mukhija S; Hjelmencrantz A
Bioorg Med Chem Lett; 2004 Dec; 14(24):5997-6000. PubMed ID: 15546716
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor.
Clements JM; Beckett RP; Brown A; Catlin G; Lobell M; Palan S; Thomas W; Whittaker M; Wood S; Salama S; Baker PJ; Rodgers HF; Barynin V; Rice DW; Hunter MG
Antimicrob Agents Chemother; 2001 Feb; 45(2):563-70. PubMed ID: 11158755
[TBL] [Abstract][Full Text] [Related]
8. Peptide deformylase inhibitors with retro-amide scaffold: synthesis and structure-activity relationships.
Lee SK; Choi KH; Lee SJ; Suh SW; Kim BM; Lee BJ
Bioorg Med Chem Lett; 2010 Aug; 20(15):4317-9. PubMed ID: 20615695
[TBL] [Abstract][Full Text] [Related]
9. Structures of Staphylococcus aureus peptide deformylase in complex with two classes of new inhibitors.
Lee SJ; Lee SJ; Lee SK; Yoon HJ; Lee HH; Kim KK; Lee BJ; Lee BI; Suh SW
Acta Crystallogr D Biol Crystallogr; 2012 Jul; 68(Pt 7):784-93. PubMed ID: 22751663
[TBL] [Abstract][Full Text] [Related]
10. 1H, 13C and 15N NMR assignments of the E. coli peptide deformylase in complex with a natural inhibitor called actinonin.
Larue V; Seijo B; Tisne C; Dardel F
Biomol NMR Assign; 2009 Jun; 3(1):153-5. PubMed ID: 19636969
[TBL] [Abstract][Full Text] [Related]
11. Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.
Hu X; Nguyen KT; Jiang VC; Lofland D; Moser HE; Pei D
J Med Chem; 2004 Sep; 47(20):4941-9. PubMed ID: 15369398
[TBL] [Abstract][Full Text] [Related]
12. Peptide deformylase inhibitors with non-peptide scaffold: synthesis and structure-activity relationships.
Lee SK; Choi KH; Lee SJ; Lee JS; Park JY; Kim BM; Lee BJ
Bioorg Med Chem Lett; 2011 Jan; 21(1):133-6. PubMed ID: 21146987
[TBL] [Abstract][Full Text] [Related]
13. Slow-binding inhibition of peptide deformylase by cyclic peptidomimetics as revealed by a new spectrophotometric assay.
Nguyen KT; Hu X; Pei D
Bioorg Chem; 2004 Jun; 32(3):178-91. PubMed ID: 15110195
[TBL] [Abstract][Full Text] [Related]
14. Kinetic analyses and inhibition studies reveal novel features in peptide deformylase 1 from Trypanosoma cruzi.
Rodrígues-Poveda CA; Pérez-Moreno G; Vidal AE; Urbina JA; González-Pacanowska D; Ruiz-Pérez LM
Mol Biochem Parasitol; 2012; 182(1-2):83-7. PubMed ID: 22209909
[TBL] [Abstract][Full Text] [Related]
15. Novel approaches to antimicrobial therapy: peptide deformylase.
Waller AS; Clements JM
Curr Opin Drug Discov Devel; 2002 Sep; 5(5):785-92. PubMed ID: 12630299
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition.
Thorarensen A; Deibel MR; Rohrer DC; Vosters AF; Yem AW; Marshall VD; Lynn JC; Bohanon MJ; Tomich PK; Zurenko GE; Sweeney MT; Jensen RM; Nielsen JW; Seest EP; Dolak LA
Bioorg Med Chem Lett; 2001 Jun; 11(11):1355-8. PubMed ID: 11378353
[TBL] [Abstract][Full Text] [Related]
17. A peptide deformylase-ribosome complex reveals mechanism of nascent chain processing.
Bingel-Erlenmeyer R; Kohler R; Kramer G; Sandikci A; Antolić S; Maier T; Schaffitzel C; Wiedmann B; Bukau B; Ban N
Nature; 2008 Mar; 452(7183):108-11. PubMed ID: 18288106
[TBL] [Abstract][Full Text] [Related]
18. Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics.
Lee MD; She Y; Soskis MJ; Borella CP; Gardner JR; Hayes PA; Dy BM; Heaney ML; Philips MR; Bornmann WG; Sirotnak FM; Scheinberg DA
J Clin Invest; 2004 Oct; 114(8):1107-16. PubMed ID: 15489958
[TBL] [Abstract][Full Text] [Related]
19. Proteome-wide analysis of the amino terminal status of Escherichia coli proteins at the steady-state and upon deformylation inhibition.
Bienvenut WV; Giglione C; Meinnel T
Proteomics; 2015 Jul; 15(14):2503-18. PubMed ID: 26017780
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship analysis of the peptide deformylase inhibitor 5-bromo-1H-indole-3-acetohydroxamic acid.
Petit S; Duroc Y; Larue V; Giglione C; Léon C; Soulama C; Denis A; Dardel F; Meinnel T; Artaud I
ChemMedChem; 2009 Feb; 4(2):261-75. PubMed ID: 19053131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
